Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

39.10
Delayed Data
As of 11:43am ET
 +0.50 / +1.31%
Today’s Change
21.53
Today|||52-Week Range
41.20
+16.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues12.8M10.4M9.0M7.5M
 
 
 
 
 
Depreciation And Amortization455.0K493.0K528.0K552.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses15.5M17.0M17.9M20.1M
 
 
 
 
 
Research And Development11.5M12.5M13.0M15.4M
 
 
 
 
 
Total Operating Expenses15.9M17.5M18.5M20.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.1M-7.0M-9.5M-13.1M
 
 
 
 
 
Extraordinary Charge-15.0K-13.0K-15.0K-17.0K
 
 
 
 
 
Interest Expense On Debt11.0K12.0K8.0K11.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.6M-6.5M-9.0M-12.5M
 
 
 
 
 
Income Taxes-826.0K-1.5M-3.6M-4.1M
 
 
 
 
 
Net Income-1.8M-5.0M-5.4M-8.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.0M19.0M19.0M19.1M
 
 
 
 
 
Shares To Calculate EPS Diluted19.0M19.0M19.0M19.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.26-$0.28-$0.44
 
 
 
 
 
EPS Diluted-$0.09-$0.26-$0.28-$0.44